Immunophenotypic characteristics of the blast crisis in chronic myeloid leukemia

Revista de Investigacion Clinica

Volumn 49, Issue 1, 1997, Pages 31-36

  López Karpovitch, Xavier ^a   Cárdenas, Rocio ^a   Piedras, Josefa ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Blast crisis; Chronic myeloid leukemia; Immunophenotype; Monoclonal antibodies

Indexed keywords

LEUKOCYTE ANTIGEN;

BLAST CELL CRISIS; CHRONIC MYELOID LEUKEMIA; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; PATHOLOGY; REVIEW;

ANTIGENS, CD; BLAST CRISIS; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, MYELOID, CHRONIC;

EID: 0030628623     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Fialkow PJ, Jacobson RJ, Papayannopolou T, Penfold GK, Jacobson RT, Hansen JA. Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. Am J Med 1977;63:125-30.
2. Kantarjian HM, Deisseroth A, Kurzrock R, Estrov Z, Talpaz M. Chronic myelogenous leukemia: a concise update. Blood 1993;82:691-703.
3. Griffin JD, Todd RF, Ritz J, Nadler LM, Canellos GP, Rosenthal D, et al. Differentiation patterns in the blastic phase of chronic myeloid leukemia. Blood 1983;61:85-91.
4. O'Malley FM, Carson M. Chronic granulocytic leukemia: correlation of blastic transformation type with karyotypic evolution. Am J Hematol 1985;20:313-23.
5. Bettelheim P, Latz D, Majdic O, Paietta E, Haas O, Linkesch W, et al. Cell lineage heterogeneity in blast crisis of chronic myeloid leukemia. Br J Haematol 1985;59:395-409.
6. Hernández JM, González-Sarmiento R, Martin C, González M, Sánchez I, Corral J, et al. Immunophenotypic, genomic and clinical characteristics of blastic crisis of chronic myelogenous leukemia. Br J Haematol 1991;79:40814.
7. Matolcsy A, Izer I, Magyarlaki T, Baranyay F. Enzyme negative blastic transformation of chronic myeloproliferative disorders: immunophenotyping of blastic cell population. Haematologia 1991;24:27-37.
8. Urbano-Ispizua A, Cervantes F, Matutes E, Villamar N, Pujades A, Sierra J, et al. Immunophenotypic characteristics of blast crisis of chronic myeloid leukemia: Correlations with clinicobiological features and survival. Leukemia 1993;7:1349-54.
9. Morabito F, Callea V, Oliva B, di Celle PF, Carbone A, Mobile F, et al. Hybrid lymphoid blast crisis of chronic myeloid leukemia with both immunoglobulin and T-cell receptor gene rearrangements. Hematol Pathol 1991;5:119-24.
10. Knuutila S, Larramendy ML, Ruutu T, Helander T. Involvement of natural killer cells in chronic myeloid leukemia. Cancer Genet Cytogenet 1995;79:21-4.
11. Hirayama Y, Kohgo Y, Kanisawa Y, Fujii S, Ikeda K, Matsunaga T, et al. CD33, CD4-double positive blastic transformation in a patient with chronic myelogenous leukemia. Int J Hematol 1993;57:265-8.
12. Akashi K, Mizuno S, Harada M, Kimura N, Kinjyo M, Shibuya T, et al. T lymphoid/myeloid bilineal crisis in chronic myelogenous leukemia. Exp Hematol 1993;21:743-8.
13. Cervantes F, Urbano-Ispizua A, Escoda L, Ordi J, Montserrat E, Rozman C. Crisis blastica linfoide T de la leucemia mieloide crónica cromosoma Filadelfia positiva: análisis de tres casos. Med Clin 1993;97:21-3.
14. Advani Sh, Malhotra H, Kadam PR, Iyer RS, Nanjangud G, Saikia T, et al. T-lymphoid blast crisis in chronic myeloid leukemia. Am J Hematol 1991;36:86-92.
15. Ch'ang HJ, Tien HF, Wang CH, Chuang SM, Chen YC, Shen MC, et al. Comparison of clinical and biologic features between myeloid and lymphoid transformation of Philadelphia chromosome positive chronic myeloid leukemia. Cancer Genet Cytogenet 1993;71:87-93.
16. Sokal JE, Cox EB, Baccarani M, Tura S, Gómez GA, Robertson JE, et al. Prognostic discrimination in "good-risk" chronic granulocytic leukemia. Blood 1984;63:789-99.
17. Labardini-Méndez JR, Dillmann E. Crisis bla"stica en leucemia granulocítica crónica. Gac Med Mex 1979;115:509-13.
18. Sales V, Rojo J, Collazo J, Lagunas E, Aguilar E, Albisua L. Chronic granulocytic leukemia in blastic crisis. Prognostic factors. In vivo 1991;5:281-5.
19. Bakhshi A, Minowada J, Arnold A, Cossman J, Jensen JP, Whang-Peng J, et al. Lymphoid blast crises of chronic myelogenous leukemia represent stages in the development of B-cell precursors. New Engl J Med 1983;309:826-31.
20. Borowitz MJ, Shuster JJ, Civin CI, Carroll AJ, Look AT, Behm FG, et al. Prognostic significance of CD34 expression in childhood B-precursor acute lymphocytic leukemia: A pediatric oncology group study. J Clin Oncol 1990;8:1389-98.
21. Pui CH, Hancock ML, Head DR, Rivera GK, Look AT, Sandlund JT, et al. Clinical significance of CD34 expression in childhood acute lymphoblastic leukemia. Blood 1993;82:889-94.
22. Banavali S, Silvestri F, Hulette B, Hurtubise P, Srivastava A, Civin CI, et al. Expression of hematopoietic progenitor cell associated antigen CD34 in chronic myeloid leukemia. Leukemia Res 1991;15:603-8.
23. Orazi A, Neiman RS, Cualing H, Heerema NA, John K. CD34 immunostaining of bone marrow biopsy specimens is a reliable way to classify the phases of chronic myeloid leukemia. Am J Clin Pathol 1994;101:426-8.